Success Stories: A Chinese Postdoctoral Researcher in the field of Biomedical Sciences Secures NIW Approval in 3 Months with NAILG’s Expert Assistance and Premium Processing Service.

Client’s Testimonial:

“Thank you so much for your help and contribution during the long journey. Your responsibility and reliability are truly impressive and make the whole process very smooth. Thank you again for your effort and help.”

On January 24^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Researcher in the Field of Biomedical Sciences (Approval Notice).

General Field: Biomedical Sciences

Position at the Time of Case Filing: Postdoctoral Researcher

Country of Origin: China

State of Residence at the Time of Filing: Ohio

Approval Notice Date: January 24^th, 2025

Processing Time: 3 months (Premium Processing Requested)

Case Summary:

A biomedical sciences expert from China approached us for assistance with his National Interest Waiver (NIW) petition. Our team of experts carefully built a strong case, highlighting his academic and professional achievements to demonstrate his eligibility.

Armed with a Ph.D. in biomedical and veterinary sciences, our client, a postdoctoral researcher, is researching the role of immune cells in human diseases, including autoimmunity and tumors. His research aimed to develop novel immunotherapies for DIPG, identify new therapeutic targets, and improve treatments for cancer and autoimmune diseases, ultimately benefiting public health and the global economy. His ongoing research at one of the most prestigious national hospitals further advances targeted immunotherapies, as recognized by fellow experts.

One of his two recommendation letters emphasized:

“I am writing this letter to acknowledge [client’s] achievements in the biomedical sciences. He has advanced the field through his expertise in investigating bovine mastitis, particularly the role of Escherichia coli (E. coli) in its progression. Specifically, [client’s] research on virulence genes and antimicrobial resistance profiles is vital for developing effective mastitis management strategies for use in the dairy industry. As such, it is clear that his work is important, which informs my recommendation for his continued research in the field.”

Our team also documented his strong publication record, which includes at least 9 peer-reviewed journal articles (four first-authored) and 5 abstracts (two first-authored). His work has been cited 145 times in at least 4 highly ranked journals, demonstrating its influence in the field. Additionally, he has completed at least 18 peer reviews, a role typically reserved for esteemed researchers, further solidifying his expertise.

Furthermore, we highlighted the significance of his work by noting his research funding from the Alliance for Lupus Research (LRA), which supports advancements in treatments for lupus and other diseases in the United States.

By focusing on immunotherapy innovations, our client’s research mitigates the severity of autoimmune conditions while simultaneously facilitating more effective and personalized cancer treatments. Thus, overall, his research advances treatments for cancers and autoimmune diseases, reducing costs and improving global health and economies.

Thanks to the strength of his case, his NIW petition was approved in just under three months. We are pleased to have assisted him and wish him continued success in his career.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.